For two decades, Th1 cells have been implicated in the pathogenesis of chronic inflammatory diseases. This notion has been challenged by the discovery of IL-23 and Th17 cells as key players in mouse inflammatory disease models. Furthermore, recent genome wide association studies have found a strong association between spondylarthropathy (SpA, a group of chronic inflammatory rheumatisms) and the presence of single nucleotide polymorphisms at the *IL-23R* locus.

Our aim is to study the role of the different CD4^+^ T cell subsets in SpA and to determine whether genetic variation at *IL23R* affects IL-23 signaling and CD4^+^ T cell function.

To address these questions, we analyzed secretion of inflammatory cytokines and expression of Th17 and Th1 marker genes by CD4^+^ T cells after stimulation in the presence or absence of IL-23. We also genotyped three SNPs at the *IL23R* locus, highly associated with SpA. The minor allele of SNP rs1004819 is positively associated with disease (more frequent in the disease cohort). In contrast, the minor allele of SNPs rs11209026 and rs1343151 are "protective" (less frequent in the disease cohort).

We found that CD4^+^ T cells from patients carrying the positively associated minor allele secreted more IFNg, IL17A and IL17F. In contrast, secretion of these cytokines was decreased in patients carrying a protective minor allele.

Further support for critical role of these SNPs at *IL23R* locus on CD4^+^ T cell function comes from gene expression analysis. We observed that patients carrying the positively associated minor allele expressed higher levels of Th1 and Th17 marker genes whereas patients carrying a protective minor allele expressed lower levels of these genes.

Our results suggest that genetic variation at the IL23R locus strongly affects CD4^+^ T cell function in spondylarthropathy, and provide a link between genotype and pathology.
